31,000 shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) acquired by Continental Advisors LLC

Continental Advisors LLC acquired a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 31,000 shares of the medical instruments supplier’s stock, valued at approximately $772,000.

Other large investors have also recently made changes to their positions in the company. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in DENTSPLY SIRONA by 44.2% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 141,117 shares of the medical instruments supplier’s stock valued at $4,684,000 after buying an additional 43,230 shares during the period. Seven Eight Capital LP purchased a new position in DENTSPLY SIRONA in the first quarter valued at about $1,409,000. Illinois Municipal Retirement Fund boosted its holdings in DENTSPLY SIRONA by 369.9% in the first quarter. Illinois Municipal Retirement Fund now owns 123,580 shares of the medical instruments supplier’s stock worth $4,102,000 after acquiring an additional 97,281 shares during the period. Intech Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth about $1,202,000. Finally, Duality Advisers LP acquired a new position in shares of DENTSPLY SIRONA in the first quarter valued at about $1,166,000. 95.70% of shares are currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA stock decrease by 2.3%

Shares of XRAY opened at $26.29 on Monday. The stock has a market cap of $5.46 billion, a P/E ratio of -59.75, a PEG ratio of 1.25 and a beta of 1.00. The company has a current ratio of 1.33, a quick ratio of 0.87, and a debt-to-equity ratio of 0.57. DENTSPLY SIRONA Inc. has a 12-month low of $23.58 and a 12-month high of $37.60. The company’s 50-day moving average is $25.56, and its two-hundred-day moving average is $27.82.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Your Free Report ) last posted its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.01). The firm had revenue of $984.00 million during the quarter, compared to analysts’ expectations of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The company’s revenue for the quarter was down 4.3% year-over-year. In the same period last year, the company posted earnings of $0.51 per share. Research analysts expect that DENTSPLY SIRONA Inc. to post 1.99 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be given a dividend of $0.16 per share. This represents an annualized dividend of $0.64 and a yield of 2.43%. The ex-dividend date is Friday, September 27. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

Changes in Analyst Ratings

Several equities research analysts recently weighed in on XRAY shares. Stifel Nicolaus cut their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research note on Thursday, July 18th. Needham & Company LLC reiterated a “buy” rating and issued a $34.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Evercore ISI cut their price target on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, July 9th. Barrington Research reiterated an “outperform” rating and issued a $36.00 price objective on shares of DENTSPLY SIRONA in a research note on Friday. Finally, Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research note on Monday, 22 July. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $33.22.

Read our latest research report on DENTSPLY SIRONA

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions and Wellspect Healthcare. The company offers dental equipment including imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines and porcelain furnaces; and CAD/CAM dental technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a cost-effective full restoration of esthetic ceramic dentistry, as well as the cloud-based DS Core. platform.

Featured stories

Want to see what other hedge funds own XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).

Receive daily news and reviews for DENTSPLY SIRONA – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for DENTSPLY SIRONA and related companies with MarketBeat.com ‘s FREE daily email newsletter.